Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold (Q73634118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

S F Leung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P J Johnson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

698-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Adriamycin Activating a Recall Phenomenon After Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feet

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Potentiation of x-ray effects by actinomycin D

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Radiation recall supraglottitis. A hazard in head and neck chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Radiation-recall dermatitis in a patient treated with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Paclitaxel and radiation-recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

Docetaxel and radiation-recall severe mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

The "recall effect" in radiotherapy: is subeffective, reparable damage involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900461-3

7 January 2021

10.1016/S0959-8049(96)00461-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274459%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference